<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101461858</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35583</journal-id>
<journal-id journal-id-type="nlm-ta">Autism Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Autism Res</journal-id>
<journal-title-group>
<journal-title>Autism research : official journal of the International Society for Autism Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1939-3792</issn>
<issn pub-type="epub">1939-3806</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28842941</article-id>
<article-id pub-id-type="pmc">5773379</article-id>
<article-id pub-id-type="doi">10.1002/aur.1853</article-id>
<article-id pub-id-type="manuscript">NIHMS914406</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Characterization of early communicative behavior in mouse models of Neurofibromatosis type 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Maloney</surname>
<given-names>Susan E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chandler</surname>
<given-names>Krystal C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anastasaki</surname>
<given-names>Corina</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rieger</surname>
<given-names>Michael A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gutmann</surname>
<given-names>David H.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dougherty</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Genetics, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA</aff>
<aff id="A2">
<label>2</label>Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA</aff>
<aff id="A3">
<label>3</label>Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Dr. Joseph D. Dougherty, Washington University School of Medicine, Department of Genetics, Campus Box 8232, 660 S. Euclid Avenue, St. Louis, Mo. 63110-1093, (314) 362-0752, <email>jdougherty@genetics.wustl.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>58</lpage>
<!--elocation-id from pubmed: 10.1002/aur.1853-->
<abstract>
<title>Scientific Abstract</title>
<p id="P2">Neurofibromatosis type 1 (NF1) is a monogenic neurodevelopmental disease caused by germline loss-of-function mutations in the <italic>NF1</italic> tumor suppressor gene. Cognitive impairments are observed in approximately 80% of children with this disease, with 45–60% exhibiting autism spectrum disorder (ASD) symptomatology. In light of the high comorbidity rate between ASD and NF1, we assessed early communicative behavior by maternal-separation induced pup ultrasonic vocalizations (USV) and developmental milestones in two distinct <italic>Nf1</italic> genetically-engineered models, one modeling clinical germline heterozygous loss of <italic>Nf1</italic> function (<italic>Nf1</italic><sup>+/−</sup> mice), and a second with somatic biallelic <italic>Nf1</italic> inactivation in neuroglial progenitor cells (<italic>Nf1</italic><sup>GFAP</sup>CKO mice). We observed altered USV production in both models: <italic>Nf1</italic><sup>+/−</sup> mice exhibited both increased USVs across development and alterations in aspects of pitch, while <italic>Nf1</italic><sup>GFAP</sup>CKO mice demonstrated a decrease in USVs. Developmental milestones, such as weight, pinnae detachment and eye opening, were not disrupted in either model, indicating the USV deficits were not due to gross developmental delay, and likely reflected more specific alterations in USV circuitry. In this respect, increased whole-brain serotonin was observed in <italic>Nf1</italic><sup>+/−</sup> mice, but whole-brain levels of dopamine and its metabolites were unchanged at the age of peak USV disruption, and USV alterations did not correlate with overall level of neurofibromin loss. The early communicative phenotypes reported herein should motivate further studies into the risks mediated by haploinsufficiency and biallelic deletion of <italic>Nf1</italic> across a full battery of ASD-relevant behavioral phenotypes, and a targeted analysis of underlying circuitry disruptions.</p>
</abstract>
<kwd-group>
<kwd>Neurofibromatosis type 1</kwd>
<kwd>NF1</kwd>
<kwd>USV</kwd>
<kwd>ultrasonic vocalization</kwd>
<kwd>communication</kwd>
<kwd>mouse</kwd>
<kwd>autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>